Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#181 / 200 Total
CRBU - Caribou Biosciences Inc - Stock Price Chart
TickerCRBU [NASD, RUT]
CompanyCaribou Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap306.18MEPS (ttm)-1.45
P/E-EPS this Y-33.40%
Forward P/E-EPS next Y-13.39%
PEG-EPS past 5Y-37.16%
P/S9.17EPS next 5Y14.50%
P/B0.89EPS Q/Q-0.74%
Dividend-Sales Q/Q-30.64%
Insider Own11.56%Inst Own74.93%
Insider Trans0.00%Inst Trans8.97%
Short Float13.32%EarningsMay 07/a
Analyst Recom1.22Target Price19.75
Avg Volume1.66M52W Range3.44 - 8.59
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kanner StevenChief Scientific OfficerFeb 06 '24Option Exercise2.6930,57782,252354,037Feb 08 05:06 PM
Haurwitz Rachel E.President and CEOJun 08 '23Option Exercise2.9610,00029,60040,000Jun 09 04:31 PM
GAME - GameSquare Holdings Inc - Stock Price Chart
TickerGAME [NASD]
CompanyGameSquare Holdings Inc
CountryCanada
IndustryElectronic Gaming & Multimedia
Market Cap17.67MEPS (ttm)-4.65
P/E-EPS this Y89.79%
Forward P/E-EPS next Y82.76%
PEG-EPS past 5Y62.42%
P/S0.38EPS next 5Y-
P/B0.51EPS Q/Q89.87%
Dividend-Sales Q/Q41.06%
Insider Own52.60%Inst Own26.45%
Insider Trans0.00%Inst Trans-
Short Float0.70%EarningsApr 16/a
Analyst Recom1.00Target Price5.00
Avg Volume144.87K52W Range1.23 - 4.69
GameSquare Holdings, Inc. is an international digital media, entertainment and technology company. It engages in enabling global brands to connect with gaming and youth culture audiences. It's platform includes Code Red Esports Ltd., Cut+Sew (Zoned), Complexity Gaming, Fourth Frame Studios, Mission Supply, Frankly Media, Stream Hatchet, and Sideqik. The company was founded on April 8, 2011and is headquartered in Toronto, Canada.
CUTR - Cutera Inc - Stock Price Chart
TickerCUTR [NASD, RUT]
CompanyCutera Inc
CountryUSA
IndustryMedical Devices
Market Cap44.56MEPS (ttm)-7.30
P/E-EPS this Y3.30%
Forward P/E-EPS next Y36.10%
PEG-EPS past 5Y-29.66%
P/S0.23EPS next 5Y25.00%
P/B-EPS Q/Q19.66%
Dividend-Sales Q/Q-28.85%
Insider Own5.09%Inst Own67.02%
Insider Trans-5.86%Inst Trans-0.94%
Short Float39.37%EarningsMay 09/a
Analyst Recom2.20Target Price6.33
Avg Volume1.04M52W Range1.28 - 21.41
May-16-24 05:00PM Insider Sale at Cutera Inc (CUTR): EVP, Chief Technology Officer Michael Karavitis Sells 63,603 ... (GuruFocus.com) -9.27%
May-10-24 04:47PM Cutera, Inc. (NASDAQ:CUTR) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.05%
May-09-24 05:20PM Cutera (CUTR) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.77%
04:25PM Cutera: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM Cutera Announces First Quarter 2024 Financial Results (Business Wire)
Apr-26-24 08:00AM Cutera to Announce First Quarter Results on May 9, 2024 (Business Wire)
Apr-11-24 08:00AM Cutera Announces the North America Launch of xeo+ (Business Wire) +10.29%
Mar-28-24 01:38PM 15 Best Beauty Stocks To Invest In (Insider Monkey) +5.76%
Mar-22-24 11:40AM Cutera, Inc. (NASDAQ:CUTR) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.43%
07:07AM Q4 2023 Cutera Inc Earnings Call (Thomson Reuters StreetEvents)
Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Karavitis MichaelEVP, Chief Technology OfficerMay 16 '24Sale2.5924,94064,5950May 16 02:37 PM
Karavitis MichaelEVP, Chief Technology OfficerMay 15 '24Sale2.6727,81574,26624,940May 16 02:37 PM
Karavitis MichaelEVP, Chief Technology OfficerMay 14 '24Sale2.4510,84826,57852,755May 16 02:37 PM
Harris Taylor C.Chief Executive OfficerAug 29 '23Buy9.9130,000297,300279,336Aug 30 08:57 AM
Drummond StuartInterim CFOAug 29 '23Buy9.805,00049,00019,678Aug 30 08:56 AM
CAKE - Cheesecake Factory Inc. - Stock Price Chart
TickerCAKE [NASD, RUT]
CompanyCheesecake Factory Inc.
CountryUSA
IndustryRestaurants
Market Cap1.96BEPS (ttm)2.18
P/E17.64EPS this Y17.08%
Forward P/E10.94EPS next Y11.58%
PEG1.10EPS past 5Y-0.73%
P/S0.57EPS next 5Y16.10%
P/B5.89EPS Q/Q21.05%
Dividend2.80%Sales Q/Q2.90%
Insider Own7.54%Inst Own86.48%
Insider Trans-0.10%Inst Trans3.13%
Short Float14.52%EarningsMay 08/a
Analyst Recom2.67Target Price38.81
Avg Volume967.71K52W Range28.58 - 41.25
Cheesecake Factory, Inc. engages in the operation of restaurant chains. It operates through The Cheesecake Factory, North Italia, Other FRC and Other segments. The Cheesecake Factory segment offers appetizers, pizza, seafood, steaks, chicken, burgers, small plates, pastas, salads, sandwiches and omelettes, and a selection of gluten-free items. The North Italia segment specializes in Italian cuisine. The Other FRC segment includes brands acquired from Fox Restaurant Concepts. The Other segment consists of the Flower Child brand, along with other businesses. The company was founded by David M. Overton, Oscar Overton and Evelyn Overton in 1972 and is headquartered in Calabasas Hills, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carango KeithPRESIDENT (SUBSIDIARY)May 14 '24Sale40.103,785151,76128,072May 15 05:00 PM
CTMX - CytomX Therapeutics Inc - Stock Price Chart
TickerCTMX [NASD]
CompanyCytomX Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap147.27MEPS (ttm)0.20
P/E9.45EPS this Y-3356.86%
Forward P/E-EPS next Y-55.21%
PEG-EPS past 5Y67.21%
P/S1.24EPS next 5Y-0.90%
P/B-EPS Q/Q433.80%
Dividend-Sales Q/Q76.45%
Insider Own1.84%Inst Own59.44%
Insider Trans-5.01%Inst Trans-17.91%
Short Float4.70%EarningsMay 08/a
Analyst Recom2.29Target Price5.02
Avg Volume6.63M52W Range1.04 - 5.85
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCarthy Sean A.CEOMar 26 '24Option Exercise1.57109,768172,874634,249Mar 28 07:12 PM
McCarthy Sean A.CEOMar 19 '24Sale2.0920,22342,175524,481Mar 21 04:40 PM
BELVIN MARCIASVP, Chief Scientific OfficerMar 19 '24Sale2.0912,79526,684168,579Mar 21 04:37 PM
Landau Jeffrey BChief Business OfficerMar 19 '24Sale2.096,56213,685110,060Mar 21 04:36 PM
ROWLAND LLOYD AGeneral CounselMar 19 '24Sale2.095,26810,986117,728Mar 21 04:41 PM
CHWY - Chewy Inc - Stock Price Chart
TickerCHWY [NYSE]
CompanyChewy Inc
CountryUSA
IndustryInternet Retail
Market Cap6.98BEPS (ttm)0.09
P/E175.68EPS this Y8.69%
Forward P/E65.74EPS next Y149.40%
PEG-EPS past 5Y-
P/S0.63EPS next 5Y-
P/B13.57EPS Q/Q456.34%
Dividend-Sales Q/Q5.14%
Insider Own69.48%Inst Own23.49%
Insider Trans-4.01%Inst Trans0.20%
Short Float17.66%EarningsMay 29/b
Analyst Recom2.07Target Price22.70
Avg Volume8.91M52W Range14.69 - 40.78
Chewy, Inc. operates as a pure-play pet e-tailer in the United States. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Dania Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh SumitChief Executive OfficerMay 02 '24Sale15.1246,090697,0101,379,100May 06 04:11 PM
Mehta SatishChief Technology OfficerMay 02 '24Sale15.128,019121,270569,594May 06 04:08 PM
Singh SumitChief Executive OfficerMay 02 '24Sale15.122,63739,879138,274May 06 04:11 PM
Bowman StacyChief Accounting OfficerApr 02 '24Sale15.538,025124,609243,769Apr 04 04:05 PM
Singh SumitChief Executive OfficerApr 02 '24Sale15.536,728104,470129,991Apr 04 04:08 PM
INBS - Intelligent Bio Solutions Inc - Stock Price Chart
TickerINBS [NASD]
CompanyIntelligent Bio Solutions Inc
CountryUSA
IndustryMedical Devices
Market Cap7.02MEPS (ttm)-3.79
P/E-EPS this Y97.11%
Forward P/E-EPS next Y65.94%
PEG-EPS past 5Y-4.95%
P/S2.48EPS next 5Y-
P/B0.59EPS Q/Q74.98%
Dividend-Sales Q/Q80.24%
Insider Own0.74%Inst Own18.77%
Insider Trans0.00%Inst Trans-56.20%
Short Float3.36%EarningsMay 08/b
Analyst Recom1.00Target Price12.00
Avg Volume98.23K52W Range2.16 - 44.88
Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Simeonidis HarryCEOSep 01 '23Buy1.8550924,180Sep 05 01:21 PM
Simeonidis HarryCEOAug 31 '23Buy1.921001924,130Sep 05 01:21 PM
NWTN - NWTN Inc - Stock Price Chart
TickerNWTN [NASD]
CompanyNWTN Inc
CountryUnited Arab Emirates
IndustryAuto Manufacturers
Market Cap1.24BEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-63.64%
Dividend-Sales Q/Q-
Insider Own13.89%Inst Own0.29%
Insider Trans0.00%Inst Trans3.67%
Short Float0.02%Earnings-
Analyst Recom-Target Price-
Avg Volume69.57K52W Range2.76 - 10.98
NWTN, Inc. engages in the design and development of smart electric vehicles. It aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology. The company was founded in 2016 and is headquartered in Dubai, United Arab Emirates.
EYPT - EyePoint Pharmaceuticals Inc - Stock Price Chart
TickerEYPT [NASD, RUT]
CompanyEyePoint Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap616.63MEPS (ttm)-1.83
P/E-EPS this Y-25.99%
Forward P/E-EPS next Y-34.37%
PEG-EPS past 5Y29.57%
P/S12.33EPS next 5Y-
P/B2.36EPS Q/Q1.98%
Dividend-Sales Q/Q52.08%
Insider Own6.15%Inst Own104.35%
Insider Trans-29.39%Inst Trans-0.28%
Short Float13.51%EarningsMay 08/b
Analyst Recom1.20Target Price38.78
Avg Volume1.19M52W Range5.67 - 30.99
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GUYER DAVID RDirectorMay 14 '24Option Exercise3.349,77532,64617,175May 16 05:19 PM
GUYER DAVID RDirectorMay 14 '24Sale12.6511,625147,0455,550May 16 05:19 PM
Cormorant Asset Management, LP10% OwnerMay 06 '24Buy11.86850,00010,081,7218,325,000May 08 04:23 PM
Cormorant Asset Management, LP10% OwnerApr 18 '24Buy18.03581,76510,489,4467,475,000Apr 22 04:00 PM
Paggiarino Dario A.Chief Medical OfficerMar 30 '24Option Exercise0.0050,404092,626Apr 02 05:27 PM
CMND - Clearmind Medicine Inc - Stock Price Chart
TickerCMND [NASD]
CompanyClearmind Medicine Inc
CountryCanada
IndustryBiotechnology
Market Cap3.87MEPS (ttm)-31.40
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-24.88%
P/S-EPS next 5Y-
P/B0.77EPS Q/Q96.22%
Dividend-Sales Q/Q-
Insider Own7.75%Inst Own8.79%
Insider Trans0.00%Inst Trans-
Short Float5.51%Earnings-
Analyst Recom-Target Price-
Avg Volume1.30M52W Range0.92 - 20.40
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
11014151617181920